CCE Launches "Peptide Practice Verification"

Regardless of which peptides the FDA ultimately permits for compounding, one principle remains unchanged: higher-risk therapies deserve higher standards of quality assurance.

CCE's Peptide Practice Verification (PPV) recognizes pharmacies that voluntarily demonstrate enhanced controls for ingredient verification, regulatory compliance, scientific integrity, and patient safety through an independent, risk-based evaluation. Because confidence in compounded peptides should be verified—not assumed.

Pharmacies that sign a contract for CCE Accreditation from now until the end of APC's Compounders on Capitol Hill (Sept. 16th, 2026) will be eligible for a FREE Peptide Practice Verification.